Medicofarma Biotech Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	21	26	74	79	116	20	Upgrade
Market Cap Growth	-38.19%	-64.24%	-6.06%	-32.05%	483.23%	848.05%	Upgrade
Enterprise Value	24	28	74	78	115	20	Upgrade
Last Close Price	0.31	0.39	1.08	1.16	1.70	2.92	Upgrade
PS Ratio	75.21	21.53	98.24	18.46	34.63	5.43	Upgrade
PB Ratio	3.82	3.84	8.04	6.22	8.14	-86.63	Upgrade
P/TBV Ratio	3.87	3.89	8.17	7.09	9.46	-	Upgrade
P/OCF Ratio	-	-	10167.70	81.76	63.64	-	Upgrade
EV/Sales Ratio	86.43	23.08	98.22	18.26	34.60	5.40	Upgrade
EV/EBITDA Ratio	-	-	-	451.82	173.24	-	Upgrade
Debt / Equity Ratio	0.57	0.37	0.15	-	-	-1.69	Upgrade
Asset Turnover	0.02	0.08	0.05	0.26	0.39	4.09	Upgrade
Inventory Turnover	599.14	768.33	13.21	10.67	6.77	13.39	Upgrade
Quick Ratio	0.85	0.85	0.63	0.65	0.73	0.34	Upgrade
Current Ratio	0.85	0.85	0.63	0.69	1.00	0.62	Upgrade
Return on Equity (ROE)	-45.19%	-28.67%	-31.57%	-11.85%	-3.08%	-399.46%	Upgrade
Return on Assets (ROA)	-15.00%	-10.76%	-10.50%	-5.95%	-2.07%	-25.48%	Upgrade
Return on Capital (ROIC)	-22.96%	-15.98%	-14.19%	-7.35%	-2.48%	-43.37%	Upgrade
Earnings Yield	-15.27%	-8.72%	-4.66%	-2.02%	-0.19%	-4.62%	Upgrade
FCF Yield	-	-3.86%	-1.49%	-0.32%	-0.42%	-1.57%	Upgrade
Buyback Yield / Dilution	-	-	-	-	-901.99%	-	Upgrade

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.